Elevated Level of PKMζ Underlies the Excessive Anxiety in an Autism Model.

Xiaoli Gao,Rui Zheng,Xiaoyan Ma,Zhiting Gong,Dan Xia,Qiang Zhou
DOI: https://doi.org/10.3389/fnmol.2019.00291
2019-01-01
Frontiers in Molecular Neuroscience
Abstract:Anxiety affects the life quality of a significant percentage of autism patients. To understand the possible biological basis of this high anxiety level, we used a valproic acid (VPA) model of autism. Anxiety level is significantly higher in VPA-injected mice, at both P35 and P70. In addition, protein kinase M zeta (PKM zeta) level in the basolateral amygdala (BLA) is significantly higher in VPA mice at both ages. Consistent with this finding, infusion of a PKM zeta-blocking peptide z-pseudosubstrate inhibitory peptide (ZIP) into BLA significantly reduced anxiety levels in VPA mice. Furthermore, viral overexpression of PKM zeta in the BLA led to elevated anxiety level in Wild Type (WT) mice, with concomitant higher intrinsic excitability of BLA excitatory neurons. Altogether, our results indicate a key contribution of BLA PKM zeta level to anxiety, especially in autism; and this finding may provide a further understanding of the pathogenesis as well as treatment of anxiety symptoms in autism patients.
What problem does this paper attempt to address?